While biologic therapy, typically with infliximab or Roferon, was used for Behçet syndrome after first-line immunosuppressants, no high-quality randomised trials or predictive biomarkers were available.
Useful Links
NEWREDMARS SKILL AND RESEARCH FOUNDATION
Registration No: 771800548 Contact Number : +91-8249516996